{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:31:56Z","timestamp":1762673516861},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2005,12,5]],"date-time":"2005-12-05T00:00:00Z","timestamp":1133740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2005,12,5]],"date-time":"2005-12-05T00:00:00Z","timestamp":1133740800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2006,1]]},"DOI":"10.1007\/s00223-005-0161-1","type":"journal-article","created":{"date-parts":[[2005,12,13]],"date-time":"2005-12-13T05:28:05Z","timestamp":1134451685000},"page":"35-44","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["The Receptor Activator of Nuclear Factor-\u03baB Ligand Inhibitor Osteoprotegerin Is a Bone-Protective Agent in a Rat Model of Chronic Renal Insufficiency and Hyperparathyroidism"],"prefix":"10.1007","volume":"78","author":[{"given":"J.","family":"Padagas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Colloton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Shalhoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Kostenuik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Morony","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Munyakazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Gianneschi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Shatzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Z.","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.-L.","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Dunstan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Lacey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2005,12,5]]},"reference":[{"key":"161_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","volume":"89","author":"WS Simonet","year":"1997","unstructured":"Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Luthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Boyle WJ (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89:309\u2013319","journal-title":"Cell"},{"key":"161_CR2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S0002-9440(10)64556-7","volume":"157","author":"DL Lacey","year":"2000","unstructured":"Lacey DL, Tan HL, Lu J, Kaufman S, Van G, Qiu W, Rattan A, Scully S, Fletcher F, Juan T, Kelley M, Burgess TL, Boyle WJ, Polverino AJ (2000) Osteoprotegerin ligand modulates murine osteoclast survival in vitro and in vivo. Am J Pathol 157:435\u2013448","journal-title":"Am J Pathol"},{"key":"161_CR3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342","journal-title":"Nature"},{"key":"161_CR4","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1359\/jbmr.2001.16.2.348","volume":"16","author":"PJ Bekker","year":"2001","unstructured":"Bekker PJ, Holloway D, Nakanishi A, Arrighi M, Leese PT, Dunstan CR (2001) The effect of a single dose of osteoprotegerin in postmenopausal women. J Bone Miner Res 16:348\u2013360","journal-title":"J Bone Miner Res"},{"key":"161_CR5","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1210\/en.142.10.4295","volume":"142","author":"PJ Kostenuik","year":"2001","unstructured":"Kostenuik PJ, Capparelli C, Morony S, Adamu S, Shimamoto G, Shen V, Lacey DL, Dunstan CR (2001) OPG and PTH-(1\u201334) have additive effects on bone density and mechanical strength in osteopenic ovariectomized rats. Endocrinology 142:4295\u20134304","journal-title":"Endocrinology"},{"key":"161_CR6","first-page":"783","volume":"60","author":"C Capparelli","year":"2000","unstructured":"Capparelli C, Kostenuik PJ, Morony S, Starnes C, Weimann B, Van G, Scully S, Qi M, Lacey DL, Dunstan CR (2000) Osteoprotegerin prevents and reverses hypercalcemia in a murine model of humoral hypercalcemia of malignancy. Cancer Res 60:783\u2013787","journal-title":"Cancer Res"},{"key":"161_CR7","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1016\/S8756-3282(98)00141-0","volume":"23","author":"T Akatsu","year":"1998","unstructured":"Akatsu T, Murakami T, Ono K, Nishikawa M, Tsuda E, Mochizuki SI, Fujise N, Higashio K, Motoyoshi K, Yamamoto M, Nagata N (1998) Osteoclastogenesis inhibitory factor exhibits hypocalcemic effects in normal mice and in hypercalcemic nude mice carrying tumors associated with humoral hypercalcemia of malignancy. Bone 23:495\u2013498","journal-title":"Bone"},{"key":"161_CR8","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.exphem.2004.01.006","volume":"32","author":"PM Doran","year":"2004","unstructured":"Doran PM, Turner RT, Chen D, Facteau SM, Ludvigson JM, Khosla S, Riggs BL, Russell SJ (2004) Native osteoprotegerin gene transfer inhibits the development of murine osteolytic bone disease induced by tumor xenografts. Exp Hematol 32:351\u2013359","journal-title":"Exp Hematol"},{"key":"161_CR9","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.1182\/blood.V98.13.3527","volume":"98","author":"N Giuliani","year":"2001","unstructured":"Giuliani N, Bataille R, Mancini C, Lazzaretti M, Barille S (2001) Myeloma cells induce imbalance in the osteoprotegerin\/osteoprotegerin ligand system in the human bone marrow environment. Blood 98:3527\u20133533","journal-title":"Blood"},{"issue":"suppl 3","key":"161_CR10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1002\/cncr.11138","volume":"97","author":"JJ Body","year":"2003","unstructured":"Body JJ, Greipp P, Coleman RE, Facon T, Geurs F, Fermand JP, Harousseau JL, Lipton A, Mariette X, Williams CD, Nakanishi A, Holloway D, Martin SW, Dunstan CR, Bekker PJ (2003) A phase I study of AMGN-0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases. Cancer 97(suppl 3):887\u2013892","journal-title":"Cancer"},{"key":"161_CR11","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1385\/IR:27:2-3:287","volume":"27","author":"X Cheng","year":"2003","unstructured":"Cheng X, Kinosaki M, Murali R, Greene MI (2003) The TNF receptor superfamily: role in immune inflammation and bone formation. Immunol Res 27:287\u2013294","journal-title":"Immunol Res"},{"key":"161_CR12","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1034\/j.1600-065X.2003.00035.x","volume":"194","author":"K Vanderkerken","year":"2003","unstructured":"Vanderkerken K, Asosingh K, Croucher P, Van Camp B (2003) Multiple myeloma biology: lessons from the 5TMM models. Immunol Rev 194:196\u2013206","journal-title":"Immunol Rev"},{"key":"161_CR13","first-page":"49","volume":"1704","author":"Y Wittrant","year":"2004","unstructured":"Wittrant Y, Theoleyre S, Chipoy C, Padrines M, Blanchard F, Heymann D, Redini F (2004) RANKL\/RANK\/OPG: new therapeutic targets in bone tumours and associated osteolysis. Biochim Biophys Acta 1704:49\u201357","journal-title":"Biochim Biophys Acta"},{"key":"161_CR14","first-page":"4432","volume":"61","author":"S Morony","year":"2001","unstructured":"Morony S, Capparelli C, Sarosi I, Lacey DL, Dunstan CR, Kostenuik PJ (2001) Osteoprotegerin inhibits osteolysis and decreases skeletal tumor burden in syngeneic and nude mouse models of experimental bone metastasis. Cancer Res 61:4432\u20134436","journal-title":"Cancer Res"},{"key":"161_CR15","doi-asserted-by":"publisher","first-page":"3121","DOI":"10.1002\/art.10680","volume":"46","author":"B Bolon","year":"2002","unstructured":"Bolon B, Shalhoub V, Kostenuik PJ, Campagnuolo G, Morony S, Boyle WJ, Zack D, Feige U (2002) Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis. Arthritis Rheum 46:3121\u20133135","journal-title":"Arthritis Rheum"},{"key":"161_CR16","first-page":"430","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"WG Goodman","year":"2003","unstructured":"Goodman WG, Coburn JW, Slatopolsky E, Salusky IB, Quarles LD (2003) Renal osteodystrophy in adults and children. In: Favus MJ (ed), Primer on the metabolic bone diseases and disorders of mineral metabolism. American Society for Bone and Mineral Research, Washington DC, pp 430\u2013447"},{"key":"161_CR17","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1359\/jbmr.1998.13.8.1213","volume":"13","author":"AM Parfitt","year":"1998","unstructured":"Parfitt AM (1998) A structural approach to renal bone disease. J Bone Miner Res 13:1213\u20131220","journal-title":"J Bone Miner Res"},{"key":"161_CR18","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1007\/BF01137964","volume":"13","author":"G Jablonski","year":"1993","unstructured":"Jablonski G, Klem KH, Attramadal A, Dahl E, Ronningen H, Gautvik KM, Haug E, Gordeladze JO (1993) Surgically induced uremia in rats. I: Effect on bone strength and metabolism. Biosci Rep 13:275\u2013287","journal-title":"Biosci Rep"},{"key":"161_CR19","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/BF00310407","volume":"55","author":"G Jablonski","year":"1994","unstructured":"Jablonski G, Danielsen CC, Mosekilde L, Gordeladze JO (1994) Surgically induced uremia in rats. II: Osseous PTH-susceptible signaling systems as predictors of bone resorption. Calcif Tissue Int 55:281\u2013287","journal-title":"Calcif Tissue Int"},{"key":"161_CR20","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/S8756-3282(98)00098-2","volume":"23","author":"MA Miller","year":"1998","unstructured":"Miller MA, Chin J, Miller SC, Fox J (1998) Disparate effects of mild, moderate, and severe secondary hyperparathyroidism on cancellous and cortical bone in rats with chronic renal insufficiency. Bone 23:257\u2013266","journal-title":"Bone"},{"key":"161_CR21","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1046\/j.1523-1755.1998.00782.x","volume":"53","author":"M Wada","year":"1998","unstructured":"Wada M, Ishii H, Furuya Y, Fox J, Nemeth EF, Nagano N (1998) NPS R-568 halts or reverses osteitis fibrosa in uremic rats. Kidney Int 53:448\u2013453","journal-title":"Kidney Int"},{"key":"161_CR22","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1007\/BF00302075","volume":"57","author":"G Jablonski","year":"1995","unstructured":"Jablonski G, Mortensen BM, Klem KH, Mosekilde L, Danielsen CC, Gordeladze JO (1995) Vitamin D3 analogs and salmon calcitonin partially reverse the development of renal osteodystrophy in rats. Calcif Tissue Int 57:385\u2013391","journal-title":"Calcif Tissue Int"},{"key":"161_CR23","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1177\/009127002762491316","volume":"42","author":"T Chen","year":"2002","unstructured":"Chen T, Berenson J, Vescio R, Swift R, Gilchick A, Goodin S, LoRusso P, Ma P, Ravera C, Deckert F, Schran H, Seaman J, Skerjanec A (2002) Pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with bone metastases. J Clin Pharmacol 42:1228\u20131236","journal-title":"J Clin Pharmacol"},{"key":"161_CR24","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1093\/ndt\/gfh672","volume":"20","author":"I Avbersek-Luznik","year":"2005","unstructured":"Avbersek-Luznik I, Balon BP, Rus I, Marc J (2005) Increased bone resorption in HD patients: is it caused by elevated RANKL synthesis? Nephrol Dial Transplant 20:566\u2013570","journal-title":"Nephrol Dial Transplant"},{"key":"161_CR25","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1359\/JBMR.0301226","volume":"19","author":"JC Huang","year":"2004","unstructured":"Huang JC, Sakata T, Pfleger LL, Bencsik M, Halloran BP, Bikle DD, Nissenson RA (2004) PTH differentially regulates expression of RANKL and OPG. J Bone Miner Res 19:235\u2013244","journal-title":"J Bone Miner Res"},{"key":"161_CR26","doi-asserted-by":"publisher","first-page":"3597","DOI":"10.1073\/pnas.95.7.3597","volume":"95","author":"H Yasuda","year":"1998","unstructured":"Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T (1998) Osteoclast differentiation factor is a ligand for osteoprotegerin\/osteoclastogenesis-inhibitory factor and is identical to TRANCE\/RANKL. Proc Natl Acad Sci USA 95:3597\u20133602","journal-title":"Proc Natl Acad Sci USA"},{"key":"161_CR27","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1056\/NEJMra022308","volume":"349","author":"JT Chang","year":"2003","unstructured":"Chang JT, Green L, Beitz J (2003) Renal failure with the use of zoledronic acid. N Engl J Med 349:1676\u20131678","journal-title":"N Engl J Med"},{"key":"161_CR28","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1002\/jbmr.5650070310","volume":"7","author":"P Ammann","year":"1992","unstructured":"Ammann P, Rizzoli R, Slosman D, Bonjour J-P (1992) Sequential and precise in vivo measurement of bone mineral density in rats using dual-energy X-ray absorptiometry. J Bone Miner Res 7:311\u2013316","journal-title":"J Bone Miner Res"},{"key":"161_CR29","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1139\/cjpp-75-10-11-1257","volume":"75","author":"S Makan","year":"1997","unstructured":"Makan S, Bayley HS, Webber CE (1997) Precision and accuracy of total body bone mass and body composition measurements in the rat using X-ray-based dual photon absorptiometry. Can J Physiol Pharmacol 75:1257\u20131261","journal-title":"Can J Physiol Pharmacol"},{"key":"161_CR30","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1523-1755.2005.67103.x","volume":"67","author":"M Colloton","year":"2005","unstructured":"Colloton M, Shatzen E, Miller G, Stehman-Ereen C, Wada M, Lacey DL, Martin D (2005) Cinacalcet HCl attenuates parathyroid hyperplasia in a rat model of secondary hyperparathyroidism. Kidney Int 67:467\u2013476","journal-title":"Kidney Int"},{"key":"161_CR31","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/S8756-3282(02)00804-9","volume":"31","author":"SK Lee","year":"2002","unstructured":"Lee SK, Lorenzo JA (2002) Regulation of receptor activator of nuclear factor-kappaB ligand and osteoprotegerin mRNA expression by parathyroid hormone is predominantly mediated by the protein kinase A pathway in murine bone marrow cultures. Bone 31:252\u2013259","journal-title":"Bone"},{"key":"161_CR32","doi-asserted-by":"publisher","first-page":"4047","DOI":"10.1210\/en.142.9.4047","volume":"142","author":"YL Ma","year":"2001","unstructured":"Ma YL, Cain RL, Halladay DL, Yang X, Zeng Q, Miles RR, Chandrasekhar S, Martin TJ, Onyia JE (2001) Catabolic effects of continuous human PTH (1\u201338) in vivo is associated with sustained stimulation of RANKL and inhibition of osteoprotegerin and gene-associated bone formation. Endocrinol 142:4047\u20134054","journal-title":"Endocrinol"},{"key":"161_CR33","first-page":"45","volume":"54","author":"Z Geng","year":"2000","unstructured":"Geng Z, Monier-Faugere MC, Bauss F, Malluche HH (2000) Short-term administration of the bisphosphonate ibandronate increases bone volume and prevents hyperparathyroid bone changes in mild experimental renal failure. Clin Nephrol 54:45\u201353","journal-title":"Clin Nephrol"},{"issue":"suppl 3","key":"161_CR34","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/ndt\/11.supp3.146","volume":"11","author":"A Moscovici","year":"1996","unstructured":"Moscovici A, Bernheim J, Popovtzer MM, Rubinger D (1996) Renal osteodystrophy in rats with reduced renal mass. Nephrol Dial Transplant 11(suppl 3):146\u2013152","journal-title":"Nephrol Dial Transplant"},{"key":"161_CR35","doi-asserted-by":"publisher","first-page":"e152","DOI":"10.1159\/000074842","volume":"95","author":"JJ Kazama","year":"2003","unstructured":"Kazama JJ, Iwasaki Y, Yamato H, Murayama H, Sato M, Gejyo F, Kurokawa M, Fukagawa K (2003) Microfocus computed tomography analysis of early changes in bone microstructure in rats with chronic renal failure. Nephron Exp Nephrol 95:e152\u2013e157","journal-title":"Nephron Exp Nephrol"},{"key":"161_CR36","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1359\/jbmr.2003.18.5.852","volume":"18","author":"C Capparelli","year":"2003","unstructured":"Capparelli C, Morony S, Warmington K, Adamu S, Lacey D, Dunstan CR, Stouch B, Martin S, Kostenuik PJ (2003) Sustained antiresorptive effects after a single treatment with human recombinant osteoprotegerin (OPG): a pharmacodynamic and pharmacokinetic analysis in rats. J Bone Miner Res 18:852\u2013858","journal-title":"J Bone Miner Res"},{"key":"161_CR37","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1046\/j.1523-1755.2003.00071.x","volume":"64","author":"GS Markowitz","year":"2003","unstructured":"Markowitz GS, Fine PL, Stack JI, Kunis CL, Radhakrishnan J, Palecki W, Park J, Nasr SH, Hoh S, Siegel DS, D\u2019Agati VD (2003) Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int 64:281\u2013289","journal-title":"Kidney Int"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-005-0161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00223-005-0161-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-005-0161-1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-005-0161-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,14]],"date-time":"2022-05-14T01:15:21Z","timestamp":1652490921000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00223-005-0161-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12,5]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2006,1]]}},"alternative-id":["161"],"URL":"https:\/\/doi.org\/10.1007\/s00223-005-0161-1","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,12,5]]},"assertion":[{"value":"2 September 2005","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2005","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 December 2005","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}